| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $30,140,485 ) (Continued on the next page) |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA298812 | Assessing the impact of the substantial equivalence mechanism on the cigarette and cigar markets | 000 | 2 | NIH | 8/14/2026 | $822,602 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | T32CA085183 | Multidisciplinary Approaches to Tumor Immunology | 000 | 24 | NIH | 7/30/2026 | $137,099 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA296175 | A scalable cruciferous vegetable intervention to reduce bladder cancer recurrence and progression | 001 | 2 | NIH | 4/15/2026 | $66,423 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA296175 | A scalable cruciferous vegetable intervention to reduce bladder cancer recurrence and progression | 000 | 2 | NIH | 12/23/2025 | $597,807 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 000 | 5 | NIH | 12/12/2025 | $568,979 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 001 | 5 | NIH | 4/17/2026 | $63,219 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA285707 | Determining the Impact of Metabolic Adaptations on the Immune-Tumor Microenvironment in Metastatic Breast Cancer | 001 | 2 | NIH | 4/16/2026 | $71,908 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA285707 | Determining the Impact of Metabolic Adaptations on the Immune-Tumor Microenvironment in Metastatic Breast Cancer | 000 | 2 | NIH | 12/19/2025 | $647,178 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA266216 | Induction of interferon response by chromatin damaging anti-cancer therapy | 001 | 3 | NIH | 4/16/2026 | $39,688 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA266216 | Induction of interferon response by chromatin damaging anti-cancer therapy | 000 | 3 | NIH | 12/18/2025 | $357,193 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K12CA279869 | Preparing Nurse Scientists to Lead the Future of Oncology Research | 000 | 3 | NIH | 8/25/2026 | $778,025 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA275081 | Impact of RB activation on the pancreatic cancer epigenome and tumor microenvironment | 000 | 4 | NIH | 7/3/2026 | $505,216 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01HL167232 | Targeting CD83 to reduce leukemia relapse and GVHD after allogeneichematopoietic cell transplantation | 000 | 4 | NIH | 3/26/2026 | $675,727 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01MH126282 | Investigating how stress induced changes in maternal serotonin affect offspring development and stress resilience | 000 | 6 | NIH | 3/5/2026 | $429,250 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA267647 | Delineating the dystopian nature of the cell cycle in cancer | 000 | 5 | NIH | 5/13/2026 | $534,959 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R50CA211108 | Associate-Director Flow and Image Cytometry Roswell Park ComprehensiveCancer Center | 000 | 10 | NIH | 7/10/2026 | $342,107 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA305978 | Elucidating mechanisms underlying lung cancer lineage plasticity thatfacilitate adaptation and resistance to targeted therapy | 000 | 1 | NIH | 6/5/2026 | $719,951 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA312294 | Elucidating the impacts of body composition and physical activity on anti-tumor immunity and cancer control in advanced stage high-grade serous carcinoma | 000 | 1 | NIH | 5/22/2026 | $713,312 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R21CA308180 | Identification of age-regulating breast cancer dormancy genes using C. elegans dauers | 000 | 1 | NIH | 7/6/2026 | $446,112 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA308972 | Modeling neuroendocrine bladder cancer for studying the pathogenesis and improving chemotherapy responses | 000 | 1 | NIH | 4/8/2026 | $639,379 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R21CA313682 | Enhanced targeted therapy for colorectal cancer | 000 | 1 | NIH | 7/3/2026 | $446,112 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R50LM015262 | Investing in Research Software Engineering for Expert Development and Dissemination of Bioconductor | 000 | 2 | NIH | 8/31/2026 | $168,448 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R21CA315103 | Repurpose spironolactone for intravesical treatment in non-muscle invasive bladder cancer | 000 | 1 | NIH | 7/29/2026 | $446,112 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R21GM166621 | Development of AKT isoform activity peptide arrays | 000 | 1 | NIH | 8/26/2026 | $477,125 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R03DE036072 | Impact of Reduced-Exposure Nicotine Product Use on Oral Health Conditions among the High-Risk Population | 000 | 1 | NIH | 7/10/2026 | $347,000 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01HL184945 | Assessing the Respiratory Effects of Inhaling Synthetic Coolants Used as Flavor Ingredients in ENDS | 000 | 1 | NIH | 8/15/2026 | $830,722 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | F30CA318410 | Investigating PI3K Signaling in Metabolite-Mediated Immunosuppression in Ovarian Cancer | 001 | 1 | NIH | 7/31/2026 | $0 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | F30CA318410 | Investigating PI3K Signaling in Metabolite-Mediated Immunosuppression in Ovarian Cancer | 000 | 1 | NIH | 7/31/2026 | $35,666 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01DA065590 | Assessing whether use of fruit flavored ENDS relates to smoking reductions in people who smoke cigarettes: A data triangulation approach to maximize internal and external validity | 000 | 1 | NIH | 8/3/2026 | $867,448 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA304753 | Innate lymphoid Cells Drive Young Onset Lung Cancer Incidences in Females | 000 | 1 | NIH | 7/10/2026 | $706,579 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | F30CA294838 | Genetic and Ancestral Determinants of Pathological and Molecular Tumor Immune Phenotypes in A Multi-Ethnic Population of Breast Cancer Patients: An Evolutionary Perspective | 000 | 2 | NIH | 8/20/2026 | $55,114 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA240290 | Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells | 000 | 7 | NIH | 4/21/2026 | $473,358 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA272771 | The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer | 000 | 4 | NIH | 2/27/2026 | $468,436 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA279440 | The Immunomodulatory Function of Cyclin E1 in Ovarian Cancer and Therapeutic Targeting | 000 | 3 | NIH | 3/19/2026 | $505,851 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | F31CA306124 | Modulating costimulation in CAR T cells to enhance antitumor efficacy | 000 | 2 | NIH | 8/17/2026 | $35,666 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA292730 | Decipher the Molecular Mechanisms of Breast Cancer Bone Metastasis | 000 | 2 | NIH | 3/3/2026 | $689,007 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283547 | Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction | 000 | 3 | NIH | 2/27/2026 | $670,321 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | P30CA016056 | Roswell Park Cancer Center Support Grant | 000 | 49 | NIH | 7/7/2026 | $4,468,904 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | UH3CA260602 | Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting | 002 | 6 | NIH | 8/17/2026 | $645,986 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | UH3CA260602 | Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting | 001 | 6 | NIH | 7/27/2026 | $1,750,151 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01HD109750 | Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits | 000 | 5 | NIH | 9/3/2026 | $449,608 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01ES034250 | STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity | 000 | 5 | NIH | 1/1/2026 | $597,213 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283501 | MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication | 001 | 3 | NIH | 4/17/2026 | $31,622 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283501 | MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication | 000 | 3 | NIH | 4/1/2026 | $640,437 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K08CA286765 | Leveraging small molecule inhibitors to improve CD19 CAR T cell immunotherapy for KMT2A-rearranged ALL | 000 | 4 | NIH | 6/23/2026 | $196,110 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA248018 | Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies | 003 | 6 | NIH | 4/28/2026 | $396,881 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA292639 | Targeting retrotransposons for improved treatment of refractory childhood cancer | 000 | 3 | NIH | 7/7/2026 | $360,011 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA292639 | Targeting retrotransposons for improved treatment of refractory childhood cancer | 001 | 3 | NIH | 7/16/2026 | $224,100 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R35GM148071 | The Genetic Basis of Human DNA Replication Timing | 000 | 4 | NIH | 3/26/2026 | $458,040 |
|
| Loading… |
|
